RecruitingGraves Ophthalmopathy
Bimatoprost as a Treatment for Graves' Orbitopathy
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Sponsor: Johns Hopkins University
You may not qualify if…
- ✕ \-
Where it's recruiting
Washington
Seattle
Source: ClinicalTrials.gov · NCT03708627 · last updated 2026-07-16